Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPOR | P19235 | 4/20 | 0.47 |
| ▸ | MC4R | P32245 | 2/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.40 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | CRHBP | P24387 | 1/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | MC5R | P33032 | 1/20 | 0.38 |
| ▸ | MC3R | P41968 | 1/20 | 0.38 |
| ▸ | CPA1 | P15085 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16599212 | 1.00 | EPOR (0.47) | EPORMC4RCPB2MMP2MMP9 | |
| SCHEMBL2723866 | 0.80 | EPOR (0.59) | EPORMC4RCPB2MMP2MMP9 | |
| SCHEMBL2723861 | 0.80 | EPOR (0.59) | EPORMC4RCPB2MMP2MMP9 | |
| SCHEMBL594167 | 0.80 | CRHBP (0.43) | CRHBPCRHR2CPA1 | |
| SCHEMBL594166 | 0.80 | CRHBP (0.43) | CRHBPCRHR2CPA1 | |
| SCHEMBL6742334 | 0.79 | EPOR (0.46) | EPORCPB2LTA4H | |
| SCHEMBL7129391 | 0.79 | EPOR (0.49) | EPORMC4RCPB2MMP2MMP9 | |
| SCHEMBL19100377 | 0.79 | EPOR (0.49) | EPORMC4RCPB2MMP2MMP9 | |
| SCHEMBL4088184 | 0.79 | CPA3 (0.42) | CRHBPCRHR2CPA1 | |
| SCHEMBL4088187 | 0.79 | CPA3 (0.42) | CRHBPCRHR2CPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4371116-A2 | METHODS FOR OPTIMISING PROTEIN PRODUCTION | United Kingdom Research and Innovation (GB) | 2024-05-22 | — | — | EP | disclosed |
| EP-4347799-A1 | MICROORGANISMS AND USES THEREOF | United Kingdom Research and Innovation (GB) | 2024-04-10 | — | — | EP | disclosed |
| WO-2023285596-A2 | METHODS FOR OPTIMISING PROTEIN PRODUCTION | UNITED KINGDOM RESEARCH AND INNOVATION (GB) | 2023-01-19 | — | — | WO | disclosed |
| WO-2021127547-A2 | MONOCLONAL ANTIBODY FUSIONS | QUIDEL CORPORATION (US) | 2021-06-24 | — | — | WO | disclosed |
| WO-2019005973-A1 | SYNTHETASE VARIANTS FOR INCORPORATION OF BIPHENYLALANINE INTO A PEPTIDE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-01-03 | — | — | WO | disclosed |
| WO-2015048364-A1 | RECOMBINANT CELLS AND ORGANISMS HAVING PERSISTENT NONSTANDARD AMINO ACID DEPENDENCE AND METHODS OF MAKING THEM | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-04-02 | — | — | WO | disclosed |